- Home
- QGEN vs WBA Comparison
QGEN vs WBA Comparison
Compare QGEN & WBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- WBA
- Stock Information
- Founded
- QGEN 1986
- WBA 1901
- Country
- QGEN Netherlands
- WBA United States
- Employees
- QGEN N/A
- WBA N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- WBA Retail-Drug Stores and Proprietary Stores
- Sector
- QGEN Health Care
- WBA Consumer Staples
- Exchange
- QGEN Nasdaq
- WBA Nasdaq
- Market Cap
- QGEN 9.1B
- WBA 9.7B
- IPO Year
- QGEN 1996
- WBA N/A
- Fundamental
- Price
- QGEN $45.29
- WBA $11.23
- Analyst Decision
- QGEN Buy
- WBA Hold
- Analyst Count
- QGEN 8
- WBA 11
- Target Price
- QGEN $50.53
- WBA $10.59
- AVG Volume (30 Days)
- QGEN 1.5M
- WBA 11.4M
- Earning Date
- QGEN 05-07-2025
- WBA 06-26-2025
- Dividend Yield
- QGEN 2.91%
- WBA N/A
- EPS Growth
- QGEN N/A
- WBA N/A
- EPS
- QGEN 0.42
- WBA N/A
- Revenue
- QGEN $2,002,874,000.00
- WBA $151,946,000,000.00
- Revenue This Year
- QGEN $6.11
- WBA $3.90
- Revenue Next Year
- QGEN $6.10
- WBA $1.88
- P/E Ratio
- QGEN $106.78
- WBA N/A
- Revenue Growth
- QGEN 3.31
- WBA 5.08
- 52 Week Low
- QGEN $37.63
- WBA $8.08
- 52 Week High
- QGEN $47.93
- WBA $16.27
- Technical
- Relative Strength Index (RSI)
- QGEN 65.90
- WBA 54.90
- Support Level
- QGEN $44.71
- WBA $11.10
- Resistance Level
- QGEN $45.41
- WBA $11.33
- Average True Range (ATR)
- QGEN 0.64
- WBA 0.11
- MACD
- QGEN 0.25
- WBA -0.01
- Stochastic Oscillator
- QGEN 97.21
- WBA 53.33
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About WBA Walgreens Boots Alliance Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.